Yasuhiro Yanagita
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Capivasertib and fulvestrant for patients with HR-positive/HER2-negative advanced breast cancer: analysis of the subgroup of patients from Japan in the phase 3 CAPItello-291 trial.
Journal: Breast cancer (Tokyo, Japan)
Published: July 09, 2024
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Journal: Breast cancer research and treatment
Published: October 31, 2023
Phase III study of bilayer sustained-release tramadol tablets in patients with cancer pain: a double-blind parallel-group, non-inferiority study with immediate-release tramadol capsules as an active comparator.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 28, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 20, 2023
Evaluation of a novel medical device for pegfilgrastim administration.
Journal: Cancer science
Published: December 14, 2021
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer.
Journal: Breast cancer research and treatment
Published: November 25, 2019
Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study.
Journal: Cancer chemotherapy and pharmacology
Published: April 04, 2019
Metachronous bilateral breast metastases of a lung neuroendocrine tumor: A case report.
Journal: Molecular and clinical oncology
Published: February 18, 2019
Follicle-Stimulating Hormone and Estradiol Levels in Japanese Women Treated with Toremifene and Anastrozole for Two Years - A Retrospective Analysis of Data from a Prospective Randomized Trial
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 28, 2018
Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence.
Journal: Annals of surgical oncology
Published: September 15, 2018
Efficacy and safety of trastuzumab, lapatinib, and paclitaxel neoadjuvant treatment with or without prolonged exposure to anti-HER2 therapy, and with or without hormone therapy for HER2-positive primary breast cancer: a randomised, five-arm, multicentre, open-label phase II trial.
Journal: Breast cancer (Tokyo, Japan)
Published: October 17, 2017
Last Updated: 09/26/2026